Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

By A. Khorana, C. Francis, E. Culakova, N. Kuderer, G. Lyman. Journal of Thrombosis and Haemostasis, 2007

1,607 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Internal Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/ba4f3723a01adc827a1634324e4506cbc07461a4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. G. Lyman
2. J. F. Timp
3. S. Braekkan
4. M. Carrier
5. H. Versteeg
6. M. Di Nisio
7. L. Hicks
8. Agnes Y. Y. Lee

Citations in the corpus

• American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. (2021, background): “Patients with cancer are at greater risk for VTE than is the general population, resulting in considerable morbidity, mortality, and costs.(13,15-23) Approximately 20% of all cases of VTE occur in”
• Epidemiology of cancer-associated venous thrombosis. (2013, background): “In a study in 4466 cancer patients in the United States starting with chemotherapy and followed for a median of 75 days, thrombosis (including both venous and arterial events) was the second leading cause of death (n 5 13; 9%) after cancer progression (n5 100; 71%).(44) In this study, causes of deat”